L-Ile
L-Ile Brand names, L-Ile Analogs
- (2S,3S)-2-Amino-3-methylpentanoic acid
- (2S,3S)-a-Amino-b-methyl-n-valeric acid
- (2S,3S)-a-Amino-b-methylvaleric acid
- (S)-Isoleucine
- (S,S)-Isoleucine
- 2-Amino-3-methylvaleric acid
- 2S,3S-Isoleucine
- Isoleucine
- Isoleucine, L-
- L-(+)-Isoleucine
- L-Ile
- L-Isoleucine
- L-Isoleucine (JP14/USP)
- L-Norvaline, 3-methyl-, erythro-
- Pentanoic acid, 2-amino-3-methyl-, (2S,3S)-
- [S-(R*,R*)]-2-Amino-3-methylpentanoic acid
- erythro-L-Isoleucine
L-Ile Brand Names Mixture
- No information avaliable
L-Ile Chemical_Formula
C6H13N1O2
L-Ile RX_link
No information avaliable
L-Ile fda sheet
L-Ile msds (material safety sheet)
L-Ile Synthesis Reference
No information avaliable
L-Ile Molecular Weight
131.174 g/mol
L-Ile Melting Point
168-170 oC
L-Ile H2O Solubility
No information avaliable
L-Ile State
Solid
L-Ile LogP
-1.743
L-Ile Dosage Forms
Capsules, powder, tablets
L-Ile Indication
The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.
L-Ile Pharmacology
They provide ingredients for the manufacturing of other essential biochemical components in the body, some of which are utilized for the production of energy, stimulants to the upper brain and helping you to be more alert.
L-Ile Absorption
Absorbed from the small intestine by a sodium-dependent active-transport process
L-Ile side effects and Toxicity
Symptoms of hypoglycemia, increased mortality in ALS patients taking large doses of BCAAs
L-Ile Patient Information
No information avaliable
L-Ile Organisms Affected
Humans and other mammals
